MoneyWorks4Me

Cipla - Quaterly Results

12 May 2023 Evaluate
The quarter ended March 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 38937.40 millions.The Company to register a -44.39%  fall in the net profit for the quarter ended March 2023.A decline of 9194.90 millions was observed in the OP in the quarter ended March 2023 from 9415.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 38937.40 37345.90 4.26 157906.00 153808.20 2.66 157906.00 153808.20 2.66
Other Income 1197.10 3163.10 -62.15 4567.90 6667.00 -31.48 4567.90 6667.00 -31.48
PBIDT 9194.90 9415.70 -2.35 42493.70 43779.30 -2.94 42493.70 43779.30 -2.94
Interest 104.60 57.80 80.97 270.20 269.30 0.33 270.20 269.30 0.33
PBDT 7231.30 9357.90 -22.73 40364.50 43510.00 -7.23 40364.50 43510.00 -7.23
Depreciation 1615.80 1367.20 18.18 5959.10 5466.20 9.02 5959.10 5466.20 9.02
PBT 5615.50 7990.70 -29.72 34405.40 38043.80 -9.56 34405.40 38043.80 -9.56
TAX 2060.60 1598.60 28.90 9710.10 9218.00 5.34 9710.10 9218.00 5.34
Deferred Tax -385.80 -0.50 77060.00 -400.90 -276.90 44.78 -400.90 -276.90 44.78
PAT 3554.90 6392.10 -44.39 24695.30 28825.80 -14.33 24695.30 28825.80 -14.33
Equity 1614.30 1613.60 0.04 1614.30 1613.60 0.04 1614.30 1613.60 0.04
PBIDTM(%) 23.61 25.21 -6.34 26.91 28.46 -5.46 26.91 28.46 -5.46
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..